SMTL ID : 8fyz.1 (1 other biounit)

Crystal structure of human PARP1 ART domain bound to inhibitor UKTT10 (compound 13)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.40 Å

Oligo State

monomer

Ligands

2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.1: 6 residues within 4Å: Chain A: H.121, R.137, Y.148, G.153, Y.155 Ligands: YNQ.4 No protein-ligand interaction detected (PLIP) DMS.2: 8 residues within 4Å: Chain A: F.150, L.191, S.195, I.197, K.199, L.200, V.207, Y.251 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:S.195

1 x CIT: CITRIC ACID(Non-functional Binders)

CIT.3: 6 residues within 4Å: Chain A: T.84, H.85, K.162, L.243, L.244, Y.245 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:Y.245 Hydrogen bonds: A:T.84, A:H.85, A:L.244, A:Y.245, A:E.247 Salt bridges: A:H.85, A:K.162, A:K.162

1 x YNQ: (2P)-2-{3-[(4R)-3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-carbonyl]phenyl}-1H-benzimidazole-4-carboxamide(Non-covalent)

YNQ.4: 17 residues within 4Å: Chain A: W.120, H.121, G.122, S.123, N.127, I.131, L.136, R.137, G.147, Y.148, Y.155, F.156, A.157, S.163, Y.166, E.247 Ligands: DMS.1 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:Y.148, A:Y.148, A:Y.155, A:Y.155, A:A.157, A:Y.166, A:E.247 Hydrogen bonds: A:G.122, A:G.122 Water bridges: A:R.124 pi-Stacking: A:Y.166 Halogen bonds: A:R.137

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Velagapudi, U.K. et al., Novel modifications of PARP inhibitor veliparib increase PARP1 binding to DNA breaks. Biochem.J. (2024)

Release Date

2024-02-07

Peptides

Poly [ADP-ribose] polymerase 1, processed C-terminus: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Poly [ADP-ribose] polymerase 1, processed C-terminus

Related Entries With Identical Sequence